fig1

Targeting MYCN and ALK in resistant and relapsing neuroblastoma

Figure 1. A summary of the signaling connections between ALK and MYCN in neuroblastoma. The red boxes describe current therapeutic approaches that are being pursued either preclinically or in clinical studies

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/